Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)]
Academic Article
Publication Date:
2022
Short description:
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] / Rimini, M., Macarulla, T., Burgio, V., Lonardi, S., Niger, M., Scartozzi, M., Rapposelli, I.G., Aprile, G., Ratti, F., Pedica, F., Verdaguer, H., Nappo, F., Nichetti, F., Lai, E., Valgiusti, M., Cappetta, A., Fabregat-Franco, C., Fassan, M., De Braud, F., Puzzoni, M., et al.. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 177:(2022), pp. 206-207. [10.1016/j.ejca.2022.09.019]
abstract:
The authors regret that Carles Fabregat-Franco's name was incorrectly given in the original article as Carles Fabregat. This has now been corrected in the online article. The correct author details are: Carles Fabregat-Franco bb Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain The authors would like to apologize for any inconvenience caused.
Iris type:
1.1.5. Erratum
List of contributors:
Rimini, M.; Macarulla, T.; Burgio, V.; Lonardi, S.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Nappo, F.; Nichetti, F.; Lai, E.; Valgiusti, M.; Cappetta, A.; Fabregat-Franco, C.; Fassan, M.; De Braud, F.; Puzzoni, M.; Frassineti, G. L.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A.
Published in: